Gabapentin use in the neonatal intensive care unit and beyond: Single center report of 104 cases
Journal of Neonatal-Perinatal Medicine · 2023
DOI: 10.3233/npm-230015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neonatal-Perinatal Medicine, 2023. Verfasst von M Elliott und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Pediatrics, University of Virginia, Charlottesville, VA, USA. Hauptthemen laut MEDLINE: Intensive Care Units, Neonatal, Infant, Premature. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Themen: Neonatologie, Intensivpflege
Abstract (Originalsprache)
BACKGROUND: We aimed to describe our experience with gabapentin use in infants admitted to our neonatal intensive care unit (NICU), including neurodevelopmental follow-up after discharge. METHODS: We performed a retrospective medical record review of infants prescribed gabapentin during admission to the University of Virginia NICU from 01/01/2015 to 04/30/2021. We report clinical characteristics including gabapentin indication, dosing and side-effects while in the NICU, discharge data, and assessments in outpatient developmental follow-up clinic. RESULTS: Gabapentin was prescribed to 104 infants (median gestational age 29 weeks, median postmenstrual age at initiation 41 weeks). Sixty-one percent of infants were male. The primary indication was irritability in 86%, and 67% were receiving at least one other neurosedative medication. Median maximum dose was 25 mg/kg/day (IQR 15–35 mg/kg/day) and 84% were discharged home on gabapentin. The majority required equipment at discharge (64% gastrostomy or nasogastric tube feeds, 54% supplemental oxygen or mechanical ventilation, and 40% both). At the first neurodevelopmental follow-up appointment, at least one area of delay was identified in 93% of infants and by 2 years corrected age 66% had a diagnosis of global developmental delay. CONCLUSIONS: NICU patients treated with gabapentin often require complex post-discharge care and require close neurodevelopmental follow up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neonatology, Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.
- Department of Neurology and Pediatrics, University of Virginia, Charlottesville, VA, USA.
- Division of Developmental Pediatrics, Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.
Zitieren
APA
Elliott, M., Fairchild, K., Burnsed, J., Zanelli, S., Heinan, K., Goodkin, H. P., Frazier, K., & Letzkus, L. (2023). Gabapentin use in the neonatal intensive care unit and beyond: Single center report of 104 cases. Journal of Neonatal-Perinatal Medicine. https://doi.org/10.3233/npm-230015
Vancouver
Elliott M, Fairchild K, Burnsed J, Zanelli S, Heinan K, Goodkin HP, et al. Gabapentin use in the neonatal intensive care unit and beyond: Single center report of 104 cases. Journal of Neonatal-Perinatal Medicine. 2023. doi:10.3233/npm-230015
BibTeX
@article{Elliott2023,
author = {Elliott, M and Fairchild, K and Burnsed, J and Zanelli, S and Heinan, K and Goodkin, H P and Frazier, K and Letzkus, L},
title = {Gabapentin use in the neonatal intensive care unit and beyond: Single center report of 104 cases},
journal = {Journal of Neonatal-Perinatal Medicine},
year = {2023},
doi = {10.3233/npm-230015}
}
EUVIMED